- Home
- NLSP vs SSY Comparison
NLSP vs SSY Comparison
Compare NLSP & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- SSY
- Stock Information
- Founded
- NLSP 2015
- SSY 1959
- Country
- NLSP Switzerland
- SSY United States
- Employees
- NLSP N/A
- SSY N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- NLSP Health Care
- SSY Health Care
- Exchange
- NLSP Nasdaq
- SSY Nasdaq
- Market Cap
- NLSP 5.8M
- SSY 6.3M
- IPO Year
- NLSP 2021
- SSY N/A
- Fundamental
- Price
- NLSP $1.62
- SSY $0.83
- Analyst Decision
- NLSP
- SSY
- Analyst Count
- NLSP 0
- SSY 0
- Target Price
- NLSP N/A
- SSY N/A
- AVG Volume (30 Days)
- NLSP 26.4K
- SSY 8.5K
- Earning Date
- NLSP 05-27-2025
- SSY 05-13-2025
- Dividend Yield
- NLSP N/A
- SSY N/A
- EPS Growth
- NLSP N/A
- SSY N/A
- EPS
- NLSP N/A
- SSY 0.25
- Revenue
- NLSP N/A
- SSY $31,094,000.00
- Revenue This Year
- NLSP N/A
- SSY N/A
- Revenue Next Year
- NLSP N/A
- SSY N/A
- P/E Ratio
- NLSP N/A
- SSY $3.51
- Revenue Growth
- NLSP N/A
- SSY N/A
- 52 Week Low
- NLSP $1.30
- SSY $0.53
- 52 Week High
- NLSP $18.40
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- NLSP 53.77
- SSY 40.61
- Support Level
- NLSP $1.58
- SSY $0.82
- Resistance Level
- NLSP $1.75
- SSY $0.87
- Average True Range (ATR)
- NLSP 0.10
- SSY 0.04
- MACD
- NLSP 0.01
- SSY -0.01
- Stochastic Oscillator
- NLSP 55.73
- SSY 3.16
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.